-
1
-
-
33845940073
-
Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations
-
Agaimy A, Wünsch P, Hofstaedter F et al (2007) Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations. Am J Surg Pathol 31:113-120
-
(2007)
Am J Surg Pathol
, vol.31
, pp. 113-120
-
-
Agaimy, A.1
-
2
-
-
33751225088
-
High incidence of microscopic gastrointestinal stromal tumors in the stomach
-
Kawanowa K, Sakuma Y, Sakurai S et al (2006) High incidence of microscopic gastrointestinal stromal tumors in the stomach. Hum Pathol 37:1527-1535
-
(2006)
Hum Pathol
, vol.37
, pp. 1527-1535
-
-
Kawanowa, K.1
Sakuma, Y.2
Sakurai, S.3
-
3
-
-
13444270334
-
Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era - A population-based study in western Sweden
-
Nilsson B, Bümming P, Meis-Kindblom JM et al (2005) Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era - a population-based study in western Sweden. Cancer 103:821-829
-
(2005)
Cancer
, vol.103
, pp. 821-829
-
-
Nilsson B, B̈.1
-
4
-
-
14344256167
-
PDGFR- and c-kit mutated gastrointestinal stromal tumors (GIST) are characterized by distinctive histological and immunohistochemical features
-
Pauls K, Merkelbach-Bruse S, Thal D et al (2004) PDGFR- and c-kit mutated gastrointestinal stromal tumors (GIST) are characterized by distinctive histological and immunohistochemical features. Histopathology 46:166-175
-
(2004)
Histopathology
, vol.46
, pp. 166-175
-
-
Pauls, K.1
Merkelbach-Bruse, S.2
Thal, D.3
-
5
-
-
3042646931
-
A great majority of GIST with PDGFRA mutations represent gastric tumors of low or no malignant potential
-
Lasota J, Dansonka-Mieszkowska A, Sobin L et al (2004) A great majority of GIST with PDGFRA mutations represent gastric tumors of low or no malignant potential. Lab Invest 84:874-883
-
(2004)
Lab Invest
, vol.84
, pp. 874-883
-
-
Lasota, J.1
Dansonka-Mieszkowska, A.2
Sobin, L.3
-
6
-
-
32844458682
-
GIST with PDGFRA exon 14 mutations represent subset of clinically favorable gastric tumors with epithelioid morphology
-
Lasota J, Stachura J, Miettinen M (2006) GIST with PDGFRA exon 14 mutations represent subset of clinically favorable gastric tumors with epithelioid morphology. Lab Invest 86:94-100
-
(2006)
Lab Invest
, vol.86
, pp. 94-100
-
-
Lasota, J.1
Stachura, J.2
Miettinen, M.3
-
7
-
-
0031947592
-
Gastrointestinal pacemaker cell tumor (GIPACT) - Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal
-
Kindblom LG, Remotti HE, Aldenborg F et al (1998) Gastrointestinal pacemaker cell tumor (GIPACT) - Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 152:1259-1269
-
(1998)
Am J Pathol
, vol.152
, pp. 1259-1269
-
-
Kindblom, L.G.1
Remotti, H.E.2
Aldenborg, F.3
-
8
-
-
15644363454
-
Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors
-
DOI 10.1126/science.279.5350.577
-
Hirota S, Isozaki K, Moriyama Y et al (1998) Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279:577-580 (Pubitemid 28067289)
-
(1998)
Science
, vol.279
, Issue.5350
, pp. 577-580
-
-
Hirota, S.1
Isozaki, K.2
Moriyama, Y.3
Hashimoto, K.4
Nishida, T.5
Ishiguro, S.6
Kawano, K.7
Hanada, M.8
Kurata, A.9
Takeda, M.10
Tunio, G.M.11
Matsuzawa, Y.12
Kanakura, Y.13
Shinomura, Y.14
Kitamura, Y.15
-
9
-
-
0035810148
-
Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor
-
Joensuu H, Roberts PJ, Sarlomo-Rikala M et al (2001) Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 344:1052-1056
-
(2001)
N Engl J Med
, vol.344
, pp. 1052-1056
-
-
Joensuu, H.1
Roberts, P.J.2
Sarlomo-Rikala, M.3
-
10
-
-
33746401591
-
KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours
-
Debiec-Rychter M, Sciot R, Le Cesne A et al (2006) KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours. Eur J Cancer 42:1093-1103
-
(2006)
Eur J Cancer
, vol.42
, pp. 1093-1103
-
-
Debiec-Rychter, M.1
Sciot, R.2
Le Cesne, A.3
-
11
-
-
41749118496
-
Molecular pathobiology of gastrointestinal stromal sarcomas
-
Corless C, Heinrich M (2008) Molecular pathobiology of gastrointestinal stromal sarcomas. Annu Rev Pathol 3:557-586
-
(2008)
Annu Rev Pathol
, vol.3
, pp. 557-586
-
-
Corless, C.1
Heinrich, M.2
-
12
-
-
33750618188
-
Gastrointestinal stromal tumors: Pathology and prognosis at different sites
-
Miettinen M, Lasota J (2006) Gastrointestinal stromal tumors: Pathology and prognosis at different sites. Semin Diagn Pathol 23:70-83
-
(2006)
Semin Diagn Pathol
, vol.23
, pp. 70-83
-
-
Miettinen, M.1
Lasota, J.2
-
13
-
-
0036301722
-
Diagnosis of gastrointestinal stromal tumors: A consensus approach
-
DOI 10.1053/hupa.2002.123545
-
Fletcher CD, Berman J, Corless CL et al (2002) Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 33:459-465 (Pubitemid 34747864)
-
(2002)
Human Pathology
, vol.33
, Issue.5
, pp. 459-465
-
-
Fletcher, C.D.M.1
Berman, J.J.2
Corless, C.3
Gorstein, F.4
Lasota, J.5
Longley B.Jack6
Miettinen, M.7
O'Leary, T.J.8
Remotti, H.9
Rubin, B.P.10
Shmookler, B.11
Sobin, L.H.12
Weiss, S.W.13
-
14
-
-
66549113366
-
Gastrointestinal stromal tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up
-
ESMO Guidelines Working Group
-
Casali P, Jost L, Reichardt P et al (2009) ESMO Guidelines Working Group. Gastrointestinal stromal tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 20:iv64-iv67
-
(2009)
Ann Oncol
, vol.20
-
-
Casali, P.1
Jost, L.2
Reichardt, P.3
-
15
-
-
67349212626
-
Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST)
-
Fiore M, Palassini E, Fumagalli E et al (2009) Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST). Eur J Surg Oncol 35:739-745
-
(2009)
Eur J Surg Oncol
, vol.35
, pp. 739-745
-
-
Fiore, M.1
Palassini, E.2
Fumagalli, E.3
|